by Team Small News | Nov 12, 2025 | Glenmark, Pharma, Zydus
Zydus Lifesciences and Glenmark Pharmaceuticals have both received approvals from China’s National Medical Products Administration (NMPA) for their respective products. Zydus Lifesciences has been granted approval for Venlafaxine Extended-Release (ER) Capsules,... by Team Small News | Nov 5, 2025 | Glenmark, Pharma
The Leander Paes-Samanta Sports Academy has partnered with the Glenmark Aquatic Foundation to promote sports development at Kalinga Institute of Industrial Technology (KIIT) and Kalinga Institute of Social Sciences (KISS) in Bhubaneswar, Odisha. This collaboration... by Team Small News | Oct 25, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals Inc., USA, has announced the upcoming launch of Ropivacaine Hydrochloride Injection USP, a generic version of Naropin Injection, in November 2025. The new product will be available in three strengths: 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5...